Prestige Consumer Healthcare (NYSE:PBH) Reaches New 12-Month High Following Better-Than-Expected Earnings

Prestige Consumer Healthcare Inc. (NYSE:PBH) shares hit a new 52-week high during trading on Friday following a stronger than expected earnings report. The stock traded as high as $87.39 and last traded at $87.21, with a volume of 768028 shares traded. The stock had previously closed at $76.10.

The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on PBH. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. DA Davidson reiterated a “buy” rating and issued a $95.00 price target on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Finally, Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective on the stock. in a research note on Monday, December 9th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $85.25.

Insiders Place Their Bets

In other news, SVP Mary Beth Fritz sold 9,885 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total transaction of $810,273.45. Following the transaction, the senior vice president now owns 18,835 shares of the company’s stock, valued at $1,543,904.95. This represents a 34.42 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Ronald M. Lombardi sold 10,875 shares of the company’s stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total value of $898,275.00. Following the transaction, the chief executive officer now directly owns 320,952 shares in the company, valued at $26,510,635.20. This trade represents a 3.28 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 38,810 shares of company stock valued at $3,187,300. 1.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Several large investors have recently made changes to their positions in PBH. Kestra Investment Management LLC acquired a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at $27,000. Northwestern Mutual Wealth Management Co. increased its holdings in Prestige Consumer Healthcare by 562.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after purchasing an additional 433 shares during the last quarter. nVerses Capital LLC increased its holdings in Prestige Consumer Healthcare by 200.0% in the third quarter. nVerses Capital LLC now owns 600 shares of the company’s stock valued at $43,000 after purchasing an additional 400 shares during the last quarter. Huntington National Bank increased its holdings in Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after purchasing an additional 181 shares during the last quarter. Finally, International Assets Investment Management LLC increased its holdings in Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock valued at $83,000 after purchasing an additional 1,138 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Up 14.6 %

The business has a fifty day moving average of $79.13 and a 200 day moving average of $75.26. The firm has a market cap of $4.31 billion, a P/E ratio of 21.22, a P/E/G ratio of 2.15 and a beta of 0.50. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.